Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Jul;75(7):e13916.
doi: 10.1111/ijcp.13916. Epub 2020 Dec 20.

Risk factors of the severity of COVID-19: A meta-analysis

Affiliations
Free article
Meta-Analysis

Risk factors of the severity of COVID-19: A meta-analysis

Abdur Rahman et al. Int J Clin Pract. 2021 Jul.
Free article

Abstract

Objective: We intend to identify some probable risk factors that are responsible for the severity of COVID-19 using a meta-analysis.

Methods: The literature exploration lasted up to 18 April 2020 and through PubMed, Google Scholar, EMBASE and Cochrane Library we have identified 10 pertinent publications. To paraphrase the outcomes of autonomous researches, we have performed a random-effect meta-analysis.

Results: A total of 2272 patients' information was extracted from the selected literature. We have found gender (male) (Risk ratio [RR] = 1.29, 95% Confidence Interval [CI] 1.07 to 1.54), hypertension (RR = 1.79, 95% CI 1.57 to 2.04), diabetes (RR = 1.57, 95% CI 1.25 to 1.98), fatigue or myalgia (RR = 1.17, 95% CI 1.02 to 1.35), and smoking history (RR = 1.71, 95% CI 1.25 to 2.35) are potential risk factors for the severity of COVID-19. We found fever (RR = 1.21, 95% CI 0.66 to 2.22), cough (1.13, 95% CI 0.98 to 1.30) and diarrhoea (RR = 1.14, 95% CI 0.93 to 1.40) as insignificant risk factors for COVID-19 severity.

Conclusions: The findings of this research may be beneficial to identify patients with higher risks to provide additional medical attention from the very beginning of the treatment.

PubMed Disclaimer

References

REFERENCES

    1. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507-513. https://doi.org/10.1016/S0140-6736(20)30211-7
    1. Surveillances V. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China, 2020. China CDC Weekly. 2020;2:113-122. https://doi.org/10.3760/cma.j.issn.0254-6450.2020.02.003
    1. Grabinskinski LE, Menachery VD. Return of the coronavirus: 2019-nCoV. Viruses. 2020;12:135. https://doi.org/10.3390/v12020135
    1. Worldometers.info, Dover, Delaware, U.S.A [Cited 17 July 2020]. http://www.worldometers.info/coronavirus/#countries
    1. Heymann DL, Shindo N. COVID-19: what is next for public health? Lancet. 2020;395:542-545. https://doi.org/10.1016/S0140-6736(20)30374-3

Publication types

LinkOut - more resources